Study of Self-Recognition and Self/Other Distinction Disorders in Patients With Psychological Vulnerability
Condition(s) studied
Investigational drug(s) / intervention(s)
Double mirror device ALTER-EGO: The patient and his matched healthy volunteer will be placed on each side of the double mirror device ALTER-EGO. Both sides will be lightened alternatively or at the same time by lights, so according to the light intensity, the subject will see himself in a mirror or the other person throw a classic window. The light intensity will vary from 0 to 100% and to 100% to 0% alternatively from each side of the mirror. At each 10% variation of one side, both patient and volunteer will have to answer that question : "who do you see more : him/her or yourself ?"
EASE test: The patient will have to answer the EASE test which is a specific test to detect patient with high risk of psychosis or schizophrenia
Study summary
The main objective of this study is to establish whether there are differences in self-recognition and self/other distinction in subjects with psychological vulnerability compared to healthy volunteer controls.
Eligibility
Primary outcome measure(s)
- Average of the three M1 — Inclusion
Average of the three M1 thresholds obtained from the "round trip" manipulation repeated three times, the M1 threshold corresponding to the level of luminosity from which a subject begins to recognize himself when his own image gradually appears (during the passage of the condition glass in mirror condition).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| CHRU BREST Hôpital de Bohars | Bohars | France | Recruiting |
More University Hospital, Brest trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04945278 on ClinicalTrials.gov ↗ ← All trials in France